As of 2025-05-19, the Intrinsic Value of Telo Genomics Corp (TELO.V) is -0.12 CAD. This TELO.V valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.09 CAD, the upside of Telo Genomics Corp is -231.77%.
Based on its market price of 0.09 CAD and our intrinsic valuation, Telo Genomics Corp (TELO.V) is overvalued by 231.77%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.12 - -0.12 | -0.12 | -231.77% |
| P/E | (0.01) - (0.03) | (0.01) | -110.5% |
| DDM - Stable | (0.28) - (1.67) | (0.98) | -1186.9% |
| DDM - Multi | (0.31) - (1.44) | (0.51) | -665.9% |
| Market Cap (mil) | 9.00 |
| Beta | 0.22 |
| Outstanding shares (mil) | 100.02 |
| Enterprise Value (mil) | 6.75 |
| Market risk premium | 5.10% |
| Cost of Equity | 7.58% |
| Cost of Debt | 5.00% |
| WACC | 7.56% |